Transcriptional profiling enables molecular classification of adrenocortical tumours

European Journal of Endocrinology

Volumn 161, Issue 1, 2009, Pages 141-152

  Laurell, Cecilia ^b   Velázquez Fernández, David ^a   Lindsten, Kristina ^a   Juhlin, Christofer ^a   Enberg, Ulla ^a   Geli, Janos ^a   Höög, Anders ^a   Kjellman, Magnus ^a   Lundeberg, Joakim ^b   Hamberger, Bertil ^a   Larsson, Catharina ^a   Nilsson, Peter ^b   Bäckdahl, Martin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER A1; ALDOSTERONE; BINDING PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MEVALONATE KINASE; OXYSTEROL BINDING PROTEIN; PEROXIREDOXIN; PEROXIREDOXIN 5; SOMATOMEDIN B; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 25; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2C; UBIQUITIN FUSION DEGRADATION PROTEIN 1; UBIQUITIN SPECIFIC PEPTIDASE 4; UNCLASSIFIED DRUG; VASCULOTROPIN B; UBIQUITIN THIOLESTERASE; USP4 PROTEIN, HUMAN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING; ADENOMA; ADRENAL CORTEX TUMOR; CLASSIFICATION; DNA MICROARRAY; GENETIC TRANSCRIPTION; GENETICS; MIDDLE AGED; MORTALITY; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC; UBIQUITIN THIOLESTERASE;

EID: 67650736272     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0068     Document Type: Article

References (42)

1. Hedeland H, Ostberg G & Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica 1968 184 211-214.
2. Boushey RP & Dackiw AP. Adrenal cortical carcinoma. Current Treatment Options in Oncology 2001 2 355-364.
3. Dackiw AP, Lee JE, Gagel RF & Evans DB. Adrenal cortical carcinoma. World Journal of Surgery 2001 25 914-926.
4. Kjellman M, Kallioniemi OP, Karhu R, Hoog A, Farnebo LO, Auer G, Larsson C & Backdahl M. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Research 1996 56 4219-4223.
5. Kjellman M, Roshani L, Teh BT, Kallioniemi OP, Hoog A, Gray S, Farnebo LO, Holst M, Backdahl M & Larsson C. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. Journal of Clinical Endocrinology and Metabolism 1999 84 730-735.
6. Sidhu S, Gicquel C, Bambach CP, Campbell P, Magarey C, Robinson BG & Delbridge LW. Clinical and molecular aspects of adrenocortical tumourigenesis. ANZ Journal of Surgery 2003 73 727-738.
7. Volante M, Buttigliero C, Greco E, Berruti A & Papotti M. Pathological and molecular features of adrenocortical carcinoma: an update. Journal of Clinical Pathology 2008 61 787-793.
8. Kendrick ML, Lloyd R, Erickson L, Farley DR, Grant CS, Thompson GB, Rowland C, Young WF Jr & van Heerden JA. Adrenocortical carcinoma: surgical progress or status quo? Archives of Surgery 2001 136 543-549.
9. Herbet M, Feige JJ & Thomas M. Insights into the role of genetic alterations in adrenocortical tumorigenesis. Molecular and Cellular Endocrinology 2009 300 169-174.
10. Koch CA, Pacak K & Chrousos GP. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Journal of Clinical Endocrinology and Metabolism 2002 87 5367-5384.
11. Libe R & Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. European Journal of Endocrinology 2005 153 477-487.
12. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller HL, Loh M, Downing JR, Caligiuri MA, Bloomfield CD & Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression. Science 1999 286 531-537.
13. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO & Botstein D. Molecular portraits of human breast tumours. Nature 2000 406 747-752.
14. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL & Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 2003 100 8418-8423.
15. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty ER, Kononen J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johannsson O, Olsson H & Sauter G. Gene-expression profiles in hereditary breast cancer. New England Journal of Medicine 2001 344 539-548.
16. Velazquez-Fernandez D, Laurell C, Geli J, Hoog A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P & Backdahl M. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 2005 138 1087-1094.
17. Weiss LM, Medeiros LJ & Vickery AL Jr. Pathological features of prognostic significans in adrenocortical carcinoma. American Journal of Surgical Pathology 1989 13 202-206.
18. R-Development-Core-Team. R: A Language and Environment for Statistical Computing Vienna, Austria 2005.
19. Bengtsson H. Aroma - An R Object-Oriented Microarray Analysis Environment, Mathematical Statistics, Lund University 2005.
20. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 2004 3. Article 3.
21. Slater E, Diehl S, Langer P, Samans B, Ramaswamy A, Zielke A & Bartsch D. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. European Journal of Endocrinology 2006 154 587-598.
22. de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin P, Baudin E, Berger F, Gicguel C, Chabre O & Feige JJ. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. Journal of Clinical Endocrinology and Metabolism 2005 90 1819-1829.
23. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM & Hanash SM. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. American Journal of Pathology 2003 162 521-531.
24. Giordano T, Kuick R, Else P, Gauger P, Vinco M, Bauersfeld J, Sanders D, Thomas D, Doherty G & Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clinical Cancer Research 2009 15 668-676.
25. de Reyniès A, Assace G, David S, Tissier F, Groussin F, Dousset B, Bertagna X, Claueser E & Bertherat J. Gene expression profilling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. Journal of Clinical Oncology 2009 27 1108-1115.
26. Nosho K, Yamamoto H, Takamaru H, Hamamoto Y, Goto A, Yoshida Y, Arimura Y, Endo T, Hirata K & Imai K. A case of colorectal carcinoma in adenoma analyzed by a cDNA array. International Journal of Colorectal Disease 2005 20 287-291.
27. Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G & Lichter P. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. International Journal of Cancer 2005 114 249-256.
28. Li H & Zhang N. Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2004 12 347-349.
29. Sayer R, Lancaster J, Pittman J, Gray J, Whitaker R, Marks J & Berchuck A. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecologic Oncology 2005 96 355-361.
30. Trojan L, Bode C, Weiss C, Mayer D, Grobholz R, Alken P & Michel M. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging. European Urology 2006 49 286-292.
31. Glickman MH & Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 2002 82 373-428.
32. Gray DA, Inazawa J, Gupta K, Wong A, Ueda R & Takahashi T. Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors. Oncogene 1995 10 2179-2183.
33. Gupta K, Chevrette M & Gray DA. The Unp proto-oncogene encodes a nuclear protein. Oncogene 1994 9 1729-1731.
34. Frederick A, Rolfe M & Chiu MI. The human UNP locus at 3p21.31 encodes two tissue-selective, cytoplasmic isoforms with deubiquitinating activity that have reduced expression in small cell lung carcinoma cell lines. Oncogene 1998 16 153-165.
35. Blanchette P, Gilchrist CA, Baker RT & Gray DA. Association of UNP, a ubiquitin-specific protease, with the pocket proteins pRb, p107 and p130. Oncogene 2001 20 5533-5537.
36. DeSalle LM, Latres E, Lin D, Graner E, Montagnoli A, Baker RT, PaganoM& Loda M. The de-ubiquitinating enzyme Unp interacts - with the retinoblastoma protein. Oncogene 2001 20 5538-5542.
37. Di Donato F, Chan EK, Askanase AD, Miranda-Carus M & Buyon JP. Interaction between 52 kDa SSA/Ro and deubiquitinating enzyme UnpEL: a clue to function. International Journal of Biochemistry and Cellular Biology 2001 33 924-934.
38. Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M & Nanoff C. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Molecular Pharmacology 2006 69 1083-1094.
39. Rape M & Kirschner MW. Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 2004 432 588-595.
40. Berlingieri MT, Pallante P, Guida M, Nappi C, Masciullo V, Scambia G, Ferraro A, Leone V, Sboner A, Barbareschi M, Ferro A, Troncone G & Fusco A. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene 2007 26 2136-2140.
41. Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, Inoue H, Kuwano H & Mori M. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. International Journal of Cancer 2007 121 33-38.
42. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M & Nakagawara A. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Research 2003 63 4167-4173.